The Indian Pharmacopoeia Commission
https://thehealthmaster.com/2022/11/30/ipc-to-digitize-indian-pharmacopoeia-ip-soon/
Wednesday, November 30, 2022
IPC to digitize Indian Pharmacopoeia (IP) soon
https://thehealthmaster.com/2022/11/30/ipc-to-digitize-indian-pharmacopoeia-ip-soon/
Tuesday, November 29, 2022
NPPA releases draft working sheets for ceiling price fixation of 954 formulations
The National Pharmaceutical Pricing Authority (NPPA
https://thehealthmaster.com/2022/11/29/nppa-releases-draft-working-sheets-for-ceiling-price-fixation-of-954-formulations/
The National Pharmaceutical Pricing Authority (NPPA) has released the draft working sheets for the fixation of ceiling prices for around 954 formulations, comprising 388 medicines, based on the database from market research firm Pharmatrac for the month of July 2022.
While the total number of unique formulations for which ceiling prices are to be fixed through the move is around 819, in view of the expansions to the revised Schedule 1 and others, the number of formulations may increase beyond 954 formulations to around 1,000 formulations, said the Authority.
The ceiling price revision is following the revision of Schedule 1 of the Drugs (Price Control) Order, 2013 replacing NLEM 2015 with NLEM 2022, notified by the Department of Pharmaceuticals (DoP) on November 11, 2022.
Click for more articles on NPPA
As per the provisions of the DPCO, 2013, the ceiling prices for the medicines in Schedule I has to be fixed within 60 days from the notification of the Schedule.
While the general practice is that ceiling prices are fixed using market-based data for schedule formulation due to revisions in the first schedule, the data available for the month ending immediately before six months of notification of the revision in the first schedule, the authority beginning in July 2022, paying attention to industry associations' representations.
The associations requested the Authority not to consider the data of April 2022, which is six months prior to the date of notification of the revised Schedule 1, since it may not completely reflect the current Price to Retailer (PTR)/Maximum Retail Price (MRP) of formulations.
Click for more articles on DPCO
This is considering that the ceiling prices were revised based on the Wholesale Price Index (WPI) of 10.8 percent based on the WPI notification issued on March 30, 2022, for scheduled formulations.
The industry also stated that the market-based data to be considered for ceiling price fixation should be post-implementation of revised prices for products, considering the potential time lag for implementation with regard to imported formulations.
They requested that the NPPA consider the latest month's data, which is of October or September 2022.
There are also provisions in the amended DPCO that, for fixing or revising the ceiling price for formulations, the government may, if it is necessary to do so, consider market-based data available for any month, as deemed fit.
Besides, the NLEM, 2022 was notified on September 13, 2022, and the latest database available with NPPA as of the date of release of the NLEM was that of July 2022.
The impact of ceiling price revision based on the WPI notification dated March 30, 2022, is expected to have been captured in the Pharmatrac database by July 2022.
Because the effect of the WPI increase on market prices should be reflected in the ceiling prices to be fixed, the Authority observed that data from April 2022 may result in the fixation of ceiling prices without capturing the effect of the WPI increase.
Also, it may not be appropriate to use the March 2022 data and apply the WPI increase to it, as not all manufacturers may avail themselves of the full WPI increase, it said.
The Authority meeting held on November 23, to consider the ceiling price revision, added that in case of common formulations, the ceiling price is fixed under the earlier Schedule-I of DPCO, 2013 that is NLEM, 2015 may be taken as the base price while fixing ceiling price under the revised Schedule-I and in case of the present PTR to any line item is found to be in excess of the Maximum Permissible PTR then the same may be restricted to the such Maximum Permissible PTR.
As per para 18(1) Ceiling prices need to be revised every five years and in case of drugs for which prices were increased through notifications on July 1, 2021, the cutoff date for five years may be calculated from original fixation of ceiling price under DPCO, 2013.
However, in respect of such formulations, no differentiation in data selection may be considered and data as appearing for July, 2022 may be considered for pricing, added.
The Authority has uploaded the draft working sheets for fixation of ceiling prices of formulations for 10 working days to invite comments, if any.
“Companies may submit their representations to NPPA on the draft working sheets supporting their Price to Retailer (PTR) and Moving Annual Turnover (MAT) data along with supporting documents like copies of invoices to retailers and samples of July, 2022 in order to take necessary action in this regard.
Such representations should reach NPPA within 10 working days of the upload of draft worksheet,” added the Authority.
Further issues regarding methodology that are likely to come up during the price fixation may be taken up for deliberation in the subsequent meetings of the Authority, it maintained.
Latest on National Pharmaceutical Pricing Authority (NPPA)
Latest notifications – DPCO / NPPA
Latest Notifications: EC Act (Essential Commodities Act)
FAQs – On DPCO: Drugs (Prices Control) Order, 2013
USFDA gives nod for Levothyroxine Sodium For Injection
CDSCO gives nod to Dapagliflozin Tablets
Pharmacists deserve more recognition for their work
USFDA designates Cipla’s Goa plant as ‘OAI’
USFDA declines to approve this Lung Cancer drug
NPPA fixes Retail Price of 40 formulations: November 2022
IPC adds one IP Reference Standard & 20 new impurities to IP 2022
Govt issues draft notification to amend NDCTR, 2019
Latest Notifications regarding Pharmaceuticals
https://thehealthmaster.com/2022/11/29/nppa-releases-draft-working-sheets-for-ceiling-price-fixation-of-954-formulations/
The National Pharmaceutical Pricing Authority (NPPA) has released the draft working sheets for the fixation of ceiling prices for around 954 formulations, comprising 388 medicines, based on the database from market research firm Pharmatrac for the month of July 2022.
While the total number of unique formulations for which ceiling prices are to be fixed through the move is around 819, in view of the expansions to the revised Schedule 1 and others, the number of formulations may increase beyond 954 formulations to around 1,000 formulations, said the Authority.
The ceiling price revision is following the revision of Schedule 1 of the Drugs (Price Control) Order, 2013 replacing NLEM 2015 with NLEM 2022, notified by the Department of Pharmaceuticals (DoP) on November 11, 2022.
Click for more articles on NPPA
As per the provisions of the DPCO, 2013, the ceiling prices for the medicines in Schedule I has to be fixed within 60 days from the notification of the Schedule.
While the general practice is that ceiling prices are fixed using market-based data for schedule formulation due to revisions in the first schedule, the data available for the month ending immediately before six months of notification of the revision in the first schedule, the authority beginning in July 2022, paying attention to industry associations' representations.
The associations requested the Authority not to consider the data of April 2022, which is six months prior to the date of notification of the revised Schedule 1, since it may not completely reflect the current Price to Retailer (PTR)/Maximum Retail Price (MRP) of formulations.
Click for more articles on DPCO
This is considering that the ceiling prices were revised based on the Wholesale Price Index (WPI) of 10.8 percent based on the WPI notification issued on March 30, 2022, for scheduled formulations.
The industry also stated that the market-based data to be considered for ceiling price fixation should be post-implementation of revised prices for products, considering the potential time lag for implementation with regard to imported formulations.
They requested that the NPPA consider the latest month's data, which is of October or September 2022.
There are also provisions in the amended DPCO that, for fixing or revising the ceiling price for formulations, the government may, if it is necessary to do so, consider market-based data available for any month, as deemed fit.
Besides, the NLEM, 2022 was notified on September 13, 2022, and the latest database available with NPPA as of the date of release of the NLEM was that of July 2022.
The impact of ceiling price revision based on the WPI notification dated March 30, 2022, is expected to have been captured in the Pharmatrac database by July 2022.
Because the effect of the WPI increase on market prices should be reflected in the ceiling prices to be fixed, the Authority observed that data from April 2022 may result in the fixation of ceiling prices without capturing the effect of the WPI increase.
Also, it may not be appropriate to use the March 2022 data and apply the WPI increase to it, as not all manufacturers may avail themselves of the full WPI increase, it said.
The Authority meeting held on November 23, to consider the ceiling price revision, added that in case of common formulations, the ceiling price is fixed under the earlier Schedule-I of DPCO, 2013 that is NLEM, 2015 may be taken as the base price while fixing ceiling price under the revised Schedule-I and in case of the present PTR to any line item is found to be in excess of the Maximum Permissible PTR then the same may be restricted to the such Maximum Permissible PTR.
As per para 18(1) Ceiling prices need to be revised every five years and in case of drugs for which prices were increased through notifications on July 1, 2021, the cutoff date for five years may be calculated from original fixation of ceiling price under DPCO, 2013.
However, in respect of such formulations, no differentiation in data selection may be considered and data as appearing for July, 2022 may be considered for pricing, added.
The Authority has uploaded the draft working sheets for fixation of ceiling prices of formulations for 10 working days to invite comments, if any.
“Companies may submit their representations to NPPA on the draft working sheets supporting their Price to Retailer (PTR) and Moving Annual Turnover (MAT) data along with supporting documents like copies of invoices to retailers and samples of July, 2022 in order to take necessary action in this regard.
Such representations should reach NPPA within 10 working days of the upload of draft worksheet,” added the Authority.
Further issues regarding methodology that are likely to come up during the price fixation may be taken up for deliberation in the subsequent meetings of the Authority, it maintained.
Latest on National Pharmaceutical Pricing Authority (NPPA)
Latest notifications – DPCO / NPPA
Latest Notifications: EC Act (Essential Commodities Act)
FAQs – On DPCO: Drugs (Prices Control) Order, 2013
USFDA gives nod for Levothyroxine Sodium For Injection
CDSCO gives nod to Dapagliflozin Tablets
Pharmacists deserve more recognition for their work
USFDA designates Cipla’s Goa plant as ‘OAI’
USFDA declines to approve this Lung Cancer drug
NPPA fixes Retail Price of 40 formulations: November 2022
IPC adds one IP Reference Standard & 20 new impurities to IP 2022
Govt issues draft notification to amend NDCTR, 2019
Latest Notifications regarding Pharmaceuticals
https://thehealthmaster.com/2022/11/29/nppa-releases-draft-working-sheets-for-ceiling-price-fixation-of-954-formulations/
The National Pharmaceutical Pricing Authority (NPPA) has released the draft working sheets for the fixation of ceiling prices for around 954 formulations, comprising 388 medicines, based on the database from market research firm Pharmatrac for the month of July 2022.
While the total number of unique formulations for which ceiling prices are to be fixed through the move is around 819, in view of the expansions to the revised Schedule 1 and others, the number of formulations may increase beyond 954 formulations to around 1,000 formulations, said the Authority.
The ceiling price revision is following the revision of Schedule 1 of the Drugs (Price Control) Order, 2013 replacing NLEM 2015 with NLEM 2022, notified by the Department of Pharmaceuticals (DoP) on November 11, 2022.
Click for more articles on NPPA
As per the provisions of the DPCO, 2013, the ceiling prices for the medicines in Schedule I has to be fixed within 60 days from the notification of the Schedule.
While the general practice is that ceiling prices are fixed using market-based data for schedule formulation due to revisions in the first schedule, the data available for the month ending immediately before six months of notification of the revision in the first schedule, the authority beginning in July 2022, paying attention to industry associations' representations.
The associations requested the Authority not to consider the data of April 2022, which is six months prior to the date of notification of the revised Schedule 1, since it may not completely reflect the current Price to Retailer (PTR)/Maximum Retail Price (MRP) of formulations.
Click for more articles on DPCO
This is considering that the ceiling prices were revised based on the Wholesale Price Index (WPI) of 10.8 percent based on the WPI notification issued on March 30, 2022, for scheduled formulations.
The industry also stated that the market-based data to be considered for ceiling price fixation should be post-implementation of revised prices for products, considering the potential time lag for implementation with regard to imported formulations.
They requested that the NPPA consider the latest month's data, which is of October or September 2022.
There are also provisions in the amended DPCO that, for fixing or revising the ceiling price for formulations, the government may, if it is necessary to do so, consider market-based data available for any month, as deemed fit.
Besides, the NLEM, 2022 was notified on September 13, 2022, and the latest database available with NPPA as of the date of release of the NLEM was that of July 2022.
The impact of ceiling price revision based on the WPI notification dated March 30, 2022, is expected to have been captured in the Pharmatrac database by July 2022.
Because the effect of the WPI increase on market prices should be reflected in the ceiling prices to be fixed, the Authority observed that data from April 2022 may result in the fixation of ceiling prices without capturing the effect of the WPI increase.
Also, it may not be appropriate to use the March 2022 data and apply the WPI increase to it, as not all manufacturers may avail themselves of the full WPI increase, it said.
The Authority meeting held on November 23, to consider the ceiling price revision, added that in case of common formulations, the ceiling price is fixed under the earlier Schedule-I of DPCO, 2013 that is NLEM, 2015 may be taken as the base price while fixing ceiling price under the revised Schedule-I and in case of the present PTR to any line item is found to be in excess of the Maximum Permissible PTR then the same may be restricted to the such Maximum Permissible PTR.
As per para 18(1) Ceiling prices need to be revised every five years and in case of drugs for which prices were increased through notifications on July 1, 2021, the cutoff date for five years may be calculated from original fixation of ceiling price under DPCO, 2013.
However, in respect of such formulations, no differentiation in data selection may be considered and data as appearing for July, 2022 may be considered for pricing, added.
The Authority has uploaded the draft working sheets for fixation of ceiling prices of formulations for 10 working days to invite comments, if any.
“Companies may submit their representations to NPPA on the draft working sheets supporting their Price to Retailer (PTR) and Moving Annual Turnover (MAT) data along with supporting documents like copies of invoices to retailers and samples of July, 2022 in order to take necessary action in this regard.
Such representations should reach NPPA within 10 working days of the upload of draft worksheet,” added the Authority.
Further issues regarding methodology that are likely to come up during the price fixation may be taken up for deliberation in the subsequent meetings of the Authority, it maintained.
Latest on National Pharmaceutical Pricing Authority (NPPA)
Latest notifications – DPCO / NPPA
Latest Notifications: EC Act (Essential Commodities Act)
FAQs – On DPCO: Drugs (Prices Control) Order, 2013
USFDA gives nod for Levothyroxine Sodium For Injection
CDSCO gives nod to Dapagliflozin Tablets
Pharmacists deserve more recognition for their work
USFDA designates Cipla’s Goa plant as ‘OAI’
USFDA declines to approve this Lung Cancer drug
NPPA fixes Retail Price of 40 formulations: November 2022
IPC adds one IP Reference Standard & 20 new impurities to IP 2022
Govt issues draft notification to amend NDCTR, 2019
Latest Notifications regarding Pharmaceuticals
https://thehealthmaster.com/2022/11/29/nppa-releases-draft-working-sheets-for-ceiling-price-fixation-of-954-formulations/
Monday, November 28, 2022
Sunday, November 27, 2022
NPPA fixes Retail Price of 40 formulations: November 2022
Download notification No. S.O. 5388(E) dated 18-11-2022, the link is given below:
https://thehealthmaster.com/2022/11/26/nppa-fixes-retail-price-of-40-formulations-november-2022/
New Delhi: The Indian Council of Medical Research (ICMR) has issued guidelines warning against the use of antibiotics for conditions such as low-grade fever and viral bronchitis and advising doctors to follow a timeline when prescribing them.
The ICMR guidelines stated that antibiotics should be prescribed for a duration of five days for skin and soft tissue infections, five days in case of community-acquired pneumonia, and eight days for hospital-acquired pneumonia.
"A clinical diagnosis most often helps us predict causative pathogens fitting into a clinical syndrome, which would tailor the correct antibiotic rather than blindly relying on fever, procalcitonin levels, WBC counts, cultures, or radiology to make a diagnosis of infection," the guidelines said.
Click for more articles on ICMR
It stated that empiric antibiotic therapy should be limited to seriously ill patients.
Generally, empiric antibiotic therapy is only recommended for a select group of patients suffering from:
- Severe sepsis and septic shock,
- Community-acquired pneumonia,
- Ventilator-associated pneumonia,
- Necrotizing fasciitis.
Hence, it is important to start smart and then focus, i.e., evaluate if empiric therapy can be justified or de-escalated, and then make a plan with regard to the duration of therapy, the guidelines said.
An ICMR survey conducted between January 1 and December 31, 2021, suggested that a big chunk of patients in India may no longer benefit from the use of carbapenem, a powerful antibiotic administered mainly in ICU settings for the treatment of pneumonia, septicemia, etc., as they have developed anti-microbial resistance to it.
Click for more on use of Antibiotics
The analysis of the data pointed towards a sustained increase in drug-resistant pathogens, resulting in difficulty treating certain infections with the available medicines.
Resistance to Imipenem, which is used to treat infections caused by E. coli bacteria, increased from 14 percent in 2016 to 36 percent in 2021.
The trend of decreasing susceptibility of bacteria to specific antibiotics was also observed with Klebsiella pneumonia as it registered a drop from 65 percent in 2016 to 45 percent in 2020 and was at 43 percent in 2021.
The term "susceptibility" here was used to describe the vulnerability of the bacteria to the antibiotic.
Carbapenem resistance isolates of E Coli and K pneumonia are also resistant to other antimicrobials, making it very challenging to treat carbapenem-resistant infections.
The resistance to the broad-spectrum antibiotic carbapenem with respect to infections caused by Acinetobacter baumannii bacteria was recorded in 87.5 percent of the patients who were part of the study in 2021, limiting the availability of treatment options, the ICMR report said.
According to HAI surveillance data included in this report, Acinetobacter causes almost 70 percent of urinary tract infections in critically ill (ICU) patients.
High levels of carbapenem resistance in acinetobacter baumanii are therefore very alarming and limit treatment options in these patients.
The report stated that the susceptibility of the same bacteria to minocycline is close to 50 percent, making it the most susceptible antibiotic after colistin for Acinetobacter baumannii.
In Pseudomonas aeruginosa, another bacteria that cause infections in the blood, lungs (pneumonia), or other parts of the body after surgery, there has been a consistent increase in susceptibility to all the major antipseudomonal drugs in the last few years.
According to the ICMR report, Staphylococcus aureus, which causes a wide range of clinical diseases such as skin infections such as abscesses and boils, as well as pneumonia, endocarditis, and osteomyelitis, showed greater susceptibility to erythromycin, clindamycin, ciprofloxacin, co-trimoxazole, and high-level mupirocin when compared to MRSA (Methicillin-
MRSA rates have increased every year from 2016 to 2021 (28.4 percent to 42.6 percent). Enterococci is another important pathogen that is quickly evolving, and drug susceptibility has changed considerably in the last few years.
Several fungal pathogens, like C. parapsilosis and C. glabrata, are showing increasing resistance to commonly available antifungal medicines such as fluconazole, thus requiring close monitoring in the next few years.
USFDA declines to approve this Lung Cancer drug
NPPA fixes Retail Price of 40 formulations: November 2022
IPC adds one IP Reference Standard & 20 new impurities to IP 2022
USFDA issues warning letter to Glenmark’s Goa facility
DCGI gives nod to Intranasal C-19 booster dose
USFDA issues Form 483 with 8 observations to Lupin
Drug recall: FDA issues nationwide recall for Ferric Carboxymaltose
Govt issues draft notification to amend NDCTR, 2019
Haryana: Sathi app launched to check Drugs abuse
Latest Notifications regarding Pharmaceuticals
https://thehealthmaster.com/2022/11/27/warning-for-use-of-antibiotics-for-low-grade-fever-icmr-guidelines/
Medicinal Facial: जानें skin पर क्या असर पड़ता है
Facial: फेशियल अब लिंग विशेष नहीं हैं, और न ही वे भाप मशीन और क्रीम के साथ घर आने वाले पार्लर चाची तक ही सीमित हैं.
ये काम कुछ समय के लिए आश्चर्यचकित करते हैं जबकि कई को लगता है कि उनकी त्वचा 2-3 सप्ताह के बाद पहले से भी बदतर है.
बहुत से लोग मेडिशनल-फेशियल (Medicinal Facial) के बारे में नहीं जानते हैं जो बनावट, त्वचा की टोन और उच्च कोलेजन उत्पादन को बेहतर बनाने में मदद करते हैं.
वे विशिष्ट परिस्थितियों की ओर ध्यान केंद्रित करते हैं, जैसे कि एंटी-एजिंग, मुंहासे, रंजकता, मुंहासों के धब्बे, सूरज की क्षति, निर्जलीकरण, रोसैसिया आदि.
मेडी-फेशियल के लाभ कई गुना हैं, सबसे महत्वपूर्ण यह है कि यह सुरक्षित और प्रभावी है. यह किसी भी सामान्य फेशियल की तुलना में अधिक समय तक चलने वाला होता है.
इसका कोई डाउनटाइम नहीं है, जिसका अर्थ है कि आप हल्के लालिमा के साथ घर जाते हैं जो कुछ घंटों तक रहती है. यह गैर-सर्जिकल प्रक्रिया है.संबंधित
मेडी-फेशियल कई प्रकार के होते हैं, यहां कुछ लोकप्रिय उपचार हैं
पानी या ऑक्सीजन जेट टेक्नॉलजी ऑक्सिफिकेशन: इसमें त्वचा को एक्सफोलिएट करने के लिए उच्च दबाव वाली हवा और पानी का उपयोग होता है, और साथ ही आपकी त्वचा की हाइड्रेशन को बेहतर बनाने के लिए त्वचा के घोल का उपयोग करता है.
- एंटी-एजिंग मेडी-फेशियल में: हम त्वचा की टोनिंग, लिफ्टिंग और मजबूती के लिए रेडियोफ्रीक्वेंसी, माइक्रो करंट या अल्ट्रासाउंड तरंगों का उपयोग करते हैं.
- वैम्पायर या पीआरपी मेडी-फेशियल में आपके स्वयं के रक्त को खींचने की प्रक्रिया शामिल होती है और व्युत्पन्न प्यूरिफाइड प्लेटलेट्स को ठीक लाइनों, असमान त्वचा टोन और त्वचा की गुणवत्ता में सुधार करने के लिए चेहरे पर वापस इंजेक्ट किया जाता है.
स्वास्थ्य सम्बन्धी अन्य आर्टिकल पढने के लिए यहाँ क्लिक करे
- हाइड्रैफेशियल: यह रोगियों की जरूरत के अनुसार सफाई, एक्सफोलिएशन, ब्लैकहेड्स की निकासी, हाइड्रेशन और विभिन्न सीरम के जलसेक प्रदान करता है.
- हॉलीवुड फेशियल: कोलेजन उत्पादन को प्रोत्साहित करने के लिए त्वचा की गहरी परतों को लक्षित करने के लिए कार्बन के छिलके के साथ संयुक्त चमक के लिए क्यू स्विच लेजर के उपयोग को शामिल करता है और यह तन पर भी काम करता है.
- एलईडी फेशियल: मानक फेशियल के साथ, लाल और नीले रंग की एलईडी थेरेपी को एंटी-एजिंग या मुंहासे विरोधी लाभों के लिए जोड़ा जाता है. ये रोशनी आपके उपचार को बढ़ाने में मदद करती है.
- मेडी फेशियल चुनने से पहले अपने त्वचा विशेषज्ञ से परामर्श करना जरूरी है
सर्दियों के दौरान जिन लोगों की त्वचा शुष्क होती है वे आमतौर पर अधिक हाइड्रेटिंग फेशियल चुनते हैं. किसी भी मेडी फेशियल को करने के बाद आपको हाइड्रेटेड रहना चाहिए, धीरे से साफ़ करना चाहिए और सबसे महत्वपूर्ण रूप से सनस्क्रीन का उपयोग करना चाहिए. ऐसी गतिविधियों से बचें, जिनके कारण बहुत पसीना आता है क्योंकि यह 48 घंटों के लिए त्वचा को परेशान कर सकती है. एक सप्ताह के लिए तैरने या स्टेम / सौना का उपयोग करने से बचें. एक सप्ताह के लिए चेहरे पर थ्रेडिंग या वैक्सिंग कराने के लिए अपनी त्वचा पर न जाएं. 4 से 5 दिनों के लिए किसी भी क्रीम का उपयोग करने से बचें, जिसमें रेटिनोइड्स, ग्लाइकोलिक, सैलिसिलिक या किसी भी अन्य क्रियाकलाप शामिल हों.
By: Dr. Reshma T. Vishnani (डॉ. रेशमा टी। विष्णानी, कंसल्टेंट डर्मेटोलॉजिस्ट, ट्राइकोलॉजिस्ट और एस्थेटिक डर्मेटोलॉजिस्ट, कोकिलाबेन धीरूभाई अंबानी हॉस्पिटल, मुंबई)
अस्वीकरण: व्यक्त किए गए विचार केवल लेखक के हैं। TheHealthMaster.com प्रत्यक्ष या अप्रत्यक्ष रूप से किसी भी व्यक्ति / संगठन को हुए किसी भी नुकसान के लिए जिम्मेदार नहीं होगा।
https://thehealthmaster.com/2020/12/13/medicinal-facial-%e0%a4%9c%e0%a4%be%e0%a4%a8%e0%a5%87%e0%a4%82-skin-%e0%a4%aa%e0%a4%b0-%e0%a4%95%e0%a5%8d%e0%a4%af%e0%a4%be-%e0%a4%85%e0%a4%b8%e0%a4%b0-%e0%a4%aa%e0%a4%a1%e0%a4%bc%e0%a4%a4%e0%a4%be/
NPPA fixes Retail Price of 40 formulations: November 2022
Download notification No. S.O. 5388(E) dated 18-11-2022, the link is given below:
https://thehealthmaster.com/2022/11/26/nppa-fixes-retail-price-of-40-formulations-november-2022/
Saturday, November 26, 2022
Download the Latest notifications - NPPA / DPCO | Drugs Price Control Order, National Pharmaceuticals Pricing Authority
The Govt. of India issues notifications from time to time, which are published by the Department of Publication and are printed by the Government of India Printing Presses regularly.
We have provided some of the notifications relevant to the above-said topic, Click on the below links for more information:
2022
S.O.-5389E-dt-18-11-2022-Corrigendum-to-S.-O.-2164E-dated-09.05.2022-based-on-the-decision-of-103rd-Authority-meeting-dated-10.11.2022.
S.O.-5388E-dt-18-11-2022-NPPA-has-fixed-retail-prices-of-40-formulations-under-DPCO-2013-based-on-the-decision-of-103rd-Authority-meeting-dated-10.11.2022.
S.O.-5249E-dt-11-11-2022-National-List-of-Essential-Medicines-2022-EC-Act-1955 (Drugs (Prices Control) Amendment Order, 2022)
O.M.-dt-21-10-2022-Extension-of-last-date-for-filing-statutory-forms-prescribed-under-DPCO-2013
S.O.-4595E-dt-29-09-2022-Extension-Revised-ceiling-price-of-Dextrose-Injection-in-100ml-pack-having-special-features-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-102nd-Authority-meeting-dated-27.09.2022.
S.O.-4594E-dt-29-09-2022-Extension-Revised-ceiling-price-of-Mannitol-Injection-20-in-100ml-pack-having-special-features-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-102nd-Authority-meeting-dated-27.09.2022.
S.O.-4593E-dt-29-09-2022-Extension-Revised-ceiling-price-of-Metronidazole-Injection-IP-in-100ml-pack-having-special-features-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-102nd-Authority-meeting-dated-27.09.2022.
S.O.-4592E-dt-29-09-2022-Extension-of-revised-ceiling-price-of-Ringer-Lactate-Injection-having-special-features-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-102nd-Authority-meeting-dated-27.09.2022.
S.O.-4591E-dt-29-09-2022-Extension-of-revised-ceiling-price-of-IV-Fluid-Injection-having-special-features-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-102nd-Authority-meeting-dated-27.09.2022.
S.O.-4590E-dt-29-09-2022-Extension-of-revised-price-of-Liquid-Medical-Oxygen-LMO-and-Oxygen-Inhalation-Medicinal-Gas-in-cylinder-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-Authority-meeting-dated-27
S.O.-4589E-dt-29-09-2022-Extension-of-revised-ceiling-price-of-Heparin-Injection-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-102nd-Authority-meeting-dated-27.09.2022.
S.O.-4588E-dt-29-09-2022-NPPA-has-fixed-retail-prices-of-40-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-102nd-Authority-meeting-dated-27.09.2022.
S.O.-4343E-dt-15-09-2022-Notification-regarding-extension-of-Knee-implants-under-Drugs-Prices-Control-Order-2013.
S.O.-4342E-dt-15-09-2022-NPPA-has-fixed-retail-prices-of-1-formulation-under-Drugs-Prices-Control-Order-2013-WPA-based-on-the-decision-of-101st-Authority-meeting-dated-07.09.2022.
S.O.-4341E-dt-15-09-2022-NPPA-has-fixed-retail-prices-of-36-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-101st-Authority-meeting-dated-07.09.2022.
OM-dated-25.08.2022-relating-to-fixation-of-Ceiling-Price-of-Sodium-Chloride-0.45-Injection.
S.O.-4002E-dt-24-08-2022-NPPA-has-fixed-retail-prices-of-45-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-100th-Authority-meeting-dated-05.08.2022.
S.O.-dt-29-07-2022-Notification-regarding-extension-of-capping-of-trade-margin-of-5-Medical-Devices
S.O.-2983E-dt-30-06-2022-Notification-regarding-extension-of-price-regulation-on-Oxygen-Concentrator
S.O.-2982E-dt-30-06-2022-Notification-regarding-extension-of-price-regulation-on-LMO-and-Oxygen-Inhalation
S.O.-2981E-dt-30-06-2022-NPPA-has-fixed-the-retail-prices-of-84-new-drugs-based-on-the-decision-taken-in-99th-Authority-meeting-dated-28.06.2022
S.O.-2465E-dt-30-05-2022-Notification-regarding-extension-of-TMR-notification-on-Oxygen-Concentrators
S.O.-2166-E-DT-09-05-2022-NPPA-has-revised-retail-price-of-1-formulation-under-Drugs-Prices-Control-Order-2013-based-on-review-order.
S.O.-2165E-Dt-09-05-2022-NPPA-has-fixed-retail-prices-of-18-formulations-under-Drugs-Prices-Control-Order-2013-the-price-of-which-were-applied-earlier-in-the-96th-Authority-meeting-dated-24.03.2022.
S.O.-2164E-Dt-09-04-2022-NPPA-has-fixed-retail-prices-of-66-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-97th-Authority-meeting-dated-06.05.2022.
S.O.-1833E-dt-18-04-2022-NPPA-has-fixed-retail-prices-of-15-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-96th-Authority-meeting-dated-24.03.2022
S.O.-1782E-dt-12-04-2022-NPPA-has-fixed-retail-prices-of-23-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-96th-Authority-meeting-dated-24.03.2022
S.O.-1508E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-Liquid-Medical-Oxygen-Medical-Inhalation-under-Drugs-Prices-Control-Order-2013
S.O.-1507E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-Heparin-Injection-under-Drugs-Prices-Control-Order-2013
S.O.-1506E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-Dextrose-under-Drugs-Prices-Control-Order-2013
S.O.-1505E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-Mannitol-under-Drugs-Prices-Control-Order-2013
S.O.-1504E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-Metronidazole-under-Drugs-Prices-Control-Order-2013
S.O.-1503E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-9-formulations-under-Drugs-Prices-Control-Order-2013
S.O.-1502E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-2-Coronary-stents-under-Drugs-Prices-Control-Order-2013
S.O.-1501E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-4-formulations-under-Drugs-Prices-Control-Order-2013
S.O.-1500E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-8-formulations-under-Drugs-Prices-Control-Order-2013
S.O.-1499E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-872-formulations-under-Drugs-Prices-Control-Order-2013
OM.-dt-25-03-2022-Movement-in-Wholesale-Price-Index-WPI-for-the-preceding-calendar-year-2021
S.O.-796E-dt-18-02-2022-NPPA-has-fixed-ceiling-prices-of-19-formulations-under-Drugs-Prices-Control-Order-2013
2021
S.O.-401E-dt-31-01-2022-Extension-of-Trade-Margin-Rationalization-on-5-Medical-Devices-namely-Pulse-Oximeter-Blood-Pressure-Monitoring-Machine-Nebulizer-Digital-Thermometer-and-Glucometer
S.O.-5428E-dt-28-12-2021-Extension-Revised-ceiling-price-of-Dextrose-Injection-in-100ml-pack-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-94th-Authority-meeting-dated-23.12.2021.
S.O.-5427E-dt-28-12-2021-Extension-Revised-ceiling-price-of-Mannitol-Injection-in-100ml-pack-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-94th-Authority-meeting-dated-23.12.2021.
S.O.-5426E-dt-28-12-2021-Extension-Revised-ceiling-price-of-Metronidazole-Injection-IP-in-100ml-pack-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-94th-Authority-meeting-dated-23.12.2021.
S.O.-5425E-dt-28-12-2021-NPPA-has-fixed-ceiling-prices-of-2-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-94th-Authority-meeting-dated-23.12.2021.
S.O.-5424E-dt-28-12-2021-Extension-of-price-of-Liquid-Medical-Oxygen-LMO-and-Oxygen-Inhalation-Medicinal-Gas-in-cylinder-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-94th-Authority-meeting-dated-23.12.2021.
S.O.-5423E-dt-28-12-2021-NPPA-has-fixed-retail-prices-of-28-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-94th-Authority-meeting-dated-23.12.2021.
S.O.-4885E-dt-26-11-2021-NPPA-has-fixed-ceiling-prices-of-2-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-93rd-Authority-meeting-dated-15.11.2021.
S.O.-4884E-dt-26-11-2021-NPPA-has-fixed-retail-prices-of-47-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-93rd-Authority-meeting-dated-15.11.2021.
OM-dt-22-11-2021-on-Paragraph-28-of-DPCO-2013-regarding-refusal-to-sell-drugs-by-manufacturers
S.O.-4241E-dt-12-10-2021-Addendum-to-S.-O.-3934E-dated-23.09.2021-Methotrexate-Topical-Gel
NPPA-OM-dt-30-09-2021-increase-in-GST-rate-Medical-Devices
S.O.-3939E-dt-23-09-2021-Revised-ceiling-price-of-Dextrose-Injection-in-100ml-pack-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-92nd-Authority-meeting-dated-08.09.2021.
S.O.-3938E-dt-23-09-2021-Revised-ceiling-price-of-Mannitol-Injection-20-in-100ml-pack-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-92nd-Authority-meeting-dated-08.09.2021.
S.O.-3937E-dt-23-09-2021-Revised-ceiling-price-of-Metronidazole-Injection-IP-in-100ml-pack-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-92nd-Authority-meeting-dated-08.09.2021.
S.O.-3936E-dt-23-09-2021-Extension-of-price-of-Liquid-Medical-Oxygen-LMO-and-Oxygen-Inhalation-Medicinal-Gas-in-cylinder-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-92nd-Authority-meeting-dated-08.09.2021.
S.O.-3934E-dt-23-09-2021-NPPA-has-fixed-retail-prices-of-23-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-92nd-Authority-meeting-dated-08.09.2021.
S.O.-E-dt-23-09-2021-Extension-of-revised-ceiling-price-of-Heparin-Injection-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-92nd-Authority-meeting-dated-08.09.2021.
S.O-3783E-dt-15-09-2021-NPPA-has-revised-retail-prices-of-1-formulation-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-91st-Authority-meeting-dated-29.07.2021.
S.O.-3670E-dt-10-09-2021-Regarding-ceiling-price-fixation-or-revision-of-Orthopaedic-Knee-Implants-for-Knee-Replacement-System
S.O.-3400E-dt-19-08-2021-NPPA-has-fixed-retail-prices-of-19-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-91st-Authority-meeting-dated-29.07.2021
S.O.-3249E-dt-12-08-2021-Amendment-in-paragraph-18-of-DPCO-2013
S.O-3162E-dt-06-08-2021-NPPA-has-fixed-retail-prices-of-6-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-91st-Authority-meeting-dated-29.07.2021
NPPA-Office-Memorandum-03-08-2021-Submission-of-price-related-information-for-Knee-Implants
NPPA-Office-Memorandum-dt-23-07-2021-–-for-Revised-MRPs-in-pursuance-to-the-TMR-Notification-for-5-Medical-Devices
S.O.-2899E-dt-20-07-2021-Order-on-Amendment-in-the-Drugs-Prices-Control-Order-2013-for-inclusion-on-Form-VI
S.O.-2820E-dt-14-07-2021-NPPA-has-fixed-retail-prices-of-14-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-89th-Authority-meeting-dated-28.06.2021
NPPA-S.O.-2808-dt-13-07-2021-Trade-Margin-Rationalisation-TMR-of-5-Medical-Devices
S.O.-2742E-dt-08-07-2021-NPPA-has-fixed-retail-prices-of-11-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-89th-Authority-meeting-dated-28.06.2021
NPPA-Office-Memorandum-dt-05-07-2021-On-Ceiling-or-Retail-Price-for-Amphotericin-B-Emulsion-Injection-50mg.
S.O.-2654E-dt-01-07-2021-Revision-of-price-of-3-drugs-under-Para-19-of-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-89th-Authority-meeting-dated-28.06.2021.
S.O.-2653E-dt-01-07-2021-Exemption-to-Torrent-Pharmaceutical-for-Tapentadol-Nasal-Spray-under-Para-32-of-DPCO-2013-based-on-the-decision-of-89th-Authority-meeting-dated-28.06.2021
S.O-2334E-dt-15-06-2021-NPPA-has-fixed-retail-prices-of-3-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-87th-Authority-meeting-dated-25.05.2021.
NPPA-Dt-09-06-2021-Office-Memorandum-Revised-MRP-for-Oxygen-Concentrators
NPPA-Office-Memorandum-dt-04-06-2021-In-pursuance-to-the-Notification-dated-03.06.2021-for-Oxygen-Concentrators
NPPA-order-dt-03-06-2021-Price-Cap-for-Oxygen-Concentrator-through-Trade-Margin-Rationalisation-Approach
S.O-2119E-dt-01-06-2021-NPPA-has-fixed-retail-prices-of-12-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-87th-Authority-meeting-dated-27.05.2021.
NPPA-Office-Memorandum-dt-15-05-2021-for-call-of-MRP-Data-for-Pulse-Oximeter-Oxygen-Concentrator-2021
S.O.-1859-dt-14-05-2021-NPPA-has-fixed-retail-prices-of-2-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-86th-Authority-meeting-dated-28.04.2021
S.O.-1725-dt-30-04-2021-NPPA-has-fixed-ceiling-price-of-1-formulation-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-86th-Authority-meeting-dated-28.04.2021.
S.O.-1724-dt-30-04-2-21-NPPA-has-fixed-retail-prices-of-42-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-86th-Authority-meeting-dated-28.04.2021.
NPPA-Office-memorandum-dt-17-04-2021-List-of-Reduced-Prices-of-Remdesivir-of-7-companies
NPPA-12-04-2021-Remdesivir-Contact-Details-and-Helpline-Numbers-for-availability
S.O.-1335E-dt-25-03-2021-Prices-of-Liquid-Medical-Oxygen-and-Medicinal-gas-extended-upto-30-09-2021
S.O.-1334E-dt-25-03-2021-Revised-ceiling-prices-WPI-adjusted-for-two-2-Coronary-Stents.
S.O.-1333E-dt-25-03-2021-Revised-ceiling-prices-WPI-adjusted-of-4-pack-size-of-ringer-lactate-injection-with-packages-having-special-features.
S.O.-1332E-dt-25-03-2021-Revised-ceiling-prices-WPI-adjusted-of-8-IV-Fluids-with-packages-having-special-features.
S.O.-1331E-dt-25-03-2021-Revised-ceiling-price-WPI-adjusted-of-9-scheduled-formulations-of-Schedule-INLEM-2011-under-Drugs-Prices-Control-Order2013.
S.O.-1330E-dt-25-03-2021-Revised-ceiling-price-WPI-adjusted-of-866-scheduled-formulations-of-Schedule-I-under-Drugs-Prices-Control-Order-2013.
S.O.-1329E-dt-25-03-2021-NPPA-has-fixed-ceiling-price-of-1-formulation-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-84th-Authority-meeting-dated-10.03.2021.
S.O-1328E-dt-25-03-2021-NPPA-has-fixed-retail-prices-of-35-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-84th-Authority-meeting-dated-10.03.2021.
NPPA-Office-Memorandum-dt-18-03-2021-Movement-in-Wholesale-Price-Index-WPI-for-the-preceding-calendar-year-2020
S.O.-1238-dt-17-03-2021-Extension-of-S.O.-4539E-dated-18.12.2019-of-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-84th-Authority-meeting-dated-10.03.2021
S.O.-1237-dt-17-03-2021-Extension-of-S.O.-4538E-dated-18.12.2019-of-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-84th-Authority-meeting-dated-10.03.2021
S.O.-1236-dt-17-03-2021-Extension-of-revised-ceiling-price-of-Heparin-Injection-based-on-the-decision-of-84th-Authority-meeting-dated-10.03.2021
S.O.-1235-dt-17-03-2021-NPPA-has-fixed-retail-price-of-3-formulations-after-expiry-of-exemption-granted-under-para-32-of-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-84th-Authority-meeting-dated-10.03.2021
S.O.-1208-dt-15-03-2021-NPPA-has-fixed-retail-prices-of-41-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-84th-Authority-meeting-dated-10.03.2021
NPPA-dt-12-03-2021-Monitoring-of-MRPs-for-Medical-Devices-dated-16.02.2021-with-Annexures
NPPA-dt-18-02-2021-Display-of-draft-version-of-proposed-price-calculation-sheet-for-24-proposed-retail-price-based-on-June-2020-Data-under-Para-4-of-DPCO-2013
NPPA-Office-Memorandum-dt-16-02-2021-on-Monitoring-of-MRPs-for-Medical-Devices-with-Annexures
S.-O.-575-E-dt-09-02-2021-NPPA-has-fixed-the-ceiling-prices-of-13-formulations-under-Drugs-Prices-Control-Order-2013
S.-O.-523-E-dt-04-02-2021-NPPA-has-fixed-the-ceiling-prices-of-8-formulations-under-Drugs-Prices-Control-Order-2013-relating-to-83rd-Authority-meeting-dated-27-01-2021
S.O.-508E-dt-01-02-2021-Amendment-in-Schedule-I-of-the-DPCO-2013
NPPA-Memorandum-dt-11-01-2021-Provisional-List-of-324-Over-Charging-cases-under-litigation
S.-O.-95-E-dt-08-01-2021-NPPA-has-fixed-the-ceiling-prices-of-12-formulations-under-Drugs-Prices-Control-Order-2013-relating-to-82nd-Authority-meeting-dated-23-12-2020
2020
S.-O.-4774-E-dt-31-12-2020-Price-exemption-of-FDC-of-Sun-Pharma-under-para-321-of-DPCO-2013-relating-to-82nd-Authority-meeting-dated-23-12-2020
S.-O.-4773-E-dt-31-12-2020-NPPA-has-fixed-the-ceiling-prices-of-7-formulations-under-Drugs-Prices-Control-Order-2013-relating-to-82nd-Authority-meeting-dated-23-12-2020
S. O. 4498(E) dt 11-12-2020 – NPPA has fixed the ceiling prices of 3 formulations under Drugs (Prices Control) Order, 2013 relating to 81th Authority meeting dated 24.11.2020
S.O-4333E-dt-03-12-2020-Extension-of-revised-price-of-Heparin-Injection-based-on-the-decision-of-81st-Authority-meeting-dated-24.11.2020
SO-3977-E-dt-03-11-2020-NPPA-has-fixed-the-ceiling-prices-of-2-formulations-under-Drugs-Prices-Control-Order-2013-relating-to-80th-Authority-meeting-dated-26.10.2020PDF-icon
SO-3976-E-dt-03-11-2020-NPPA-has-fixed-the-ceiling-prices-of-6-formulations-under-Drugs-Prices-Control-Order-2013-relating-to-80th-Authority-meeting-dated-26.10.2020
SO-3975-E-dt-03-11-2020-Addendum-to-SO.-1216-E-dated-25.03.2020-relating-to-80th-Authority-meeting-dated-26.10.2020
SO-3974-E-dt-03-11-2020-Addendum-to-SO.-1215-E-dated-25.03.2020-relating-to-80th-Authority-meeting-dated-26.10.2020
S.O.-3973E-dt.-03-11-2020-NPPA-has-fixed-retail-prices-of-29-formulations-under-Drugs-Prices-Control-Order-2013-relating-to-80th-Authority-meeting-dated-26-10-2020
S.O.-3322-E-dt-25-09-2020-Price-Cap-for-Medical-Liquid-Oxygen-and-Oxygen-Inhalation-Medicinal-gas-in-Cylinder
S.O.-3319-E-dt-25-09-2020-NPPA-has-fixed-retail-prices-of-26-formulations-under-Drugs-Prices-Control-Order-2013-relating-to-78th-Authority-meeting-dated-14.09.2020
Office-memorandum-dt-25-09-2020-–-Clarification-regarding-revision-of-Ceiling-Prices-of-Orthopaedic-Knee-Implants-for-the-year-2020
NPPA-order-dt-24-09-2020-for-submission-of-data-by-manufacturers-and-re-fillers-of-medical-oxygen
S.O.-3147E-15-09-2020-Notification-regarding-ceiling-price-fixation-revision-of-orthopedic-Knee-Implants-for-Knee-Replacement-System
S.O.-No.-2896-dt-27-08-2020-NPPA-has-fixed-retail-prices-of-1-formulation-under-Drugs-Prices-Control-Order-2013-relating-to-77th-Authority-meeting-dated-06.08.2020
S.O.-2822E-dt-20-08-2020-NPPA-has-fixed-retail-prices-of-29-formulations-under-Drugs-Prices-Control-Order-2013-relating-to-77th-Authority-meeting-dated-06.08.2020
NPPA-Office-memorandum-dt.-14-08-2020-Guidelines-for-Discontinuation-of-Scheduled-Formulation
S.O.-No.-2768-E-dated-14-08-2020-regarding-prices-of-Knee-implants-extended-upto-15-09-2020
S.O.-2293E-dt.-10-07-2020-NPPA-HAS-FIXED-RETAIL-PRICES-OF-7-FORMULATIONS-UNDER-DRUGS-PRICES-CONTROL-ORDER-2013-RELATING-TO-76TH-AUTHORITY-MEETING-DATED-22.06.2020
S.O.-2292E-dt.-10-07-2020-REVISION-OF-CEILING-PRICE-OF-1-FORMULATION-BASED-ON-REVIEW-ORDER-RELATING-TO-76TH-AUTHORITY-MEETING-DATED-22.06.2020
SO-2151E-dt-30-06-2020-Revised-ceiling-price-of-Heparin
S.O. 2150 dt. 30-06-2020 – NPPA has fixed retail prices of 14 formulations under Drugs (Prices Control) Order, 2013
NPPA-Office-Memorandum-dt-03-06-2020-regarding-revised-MRPs-of-N-95-masks
NPPA-dt-01-06-2020-Draft-guidelines-for-dealing-cases-of-discontinuation-of-scheduled-formulations-under-Para-21-2-of-DPCO 2013.
S.O.-1674 (E) 28-05-2020 NPPA has fixed revised retail prices of 40 formulation under Drugs (Prices Control) Order, 2013
NPPA-OM-Dt-14-08-2020-Guidelines-for-Discontinuation-of-Scheduled-Formulation
S.O-No.-1232-E-dt-31-03-2020-All-Medical-devices-under-DPCO
NPPA-Order-dated-25.03.2020-to-maintain-stock-of-Lopinavir-Ritonavir-Tablets
S.O.-1217-dt-25-03-2020-NPPA-has-fixed-revised-retail-prices-of-2-items-Stents-under-Drugs-Prices-Control-Order-2013
S.O.-1216-dt-25-03-2020-16-items-Ringer-Lactate-Price-revision-as-per-annual-wholesale-price-Index-WPI-@-1.88468-increase
S.O.-1215-dt-25-03-2020-8-items-Glucose-Sod-Chloride-etc.-Price-revision-as-per-annual-wholesale-price-Index-WPI-@-1.88468-increase
S.O.-1214-dt-25-03-2020-13-items-Salicylic-acid-Cal-carbonate-Condom-etc.-Price-revision-as-per-annual-wholesale-price-Index-WPI-@-1.88468-increase
S.O.-1213-dt-25-03-2020-856-items-Price-revision-as-per-annual-wholesale-price-Index-WPI-@-1.88468-increase
S.O.
https://thehealthmaster.com/2021/02/14/latest-notifications-nppa-dpco/
Download: NPPA / DPCO - Latest notifications
The Govt. of India issues notifications from time to time which are published by the Department of Publication and are printed by the Government of India Printing Presses regularly.
We have provided some of the notifications relevant to the above-said topic, Click the below links for more information:
Latest Notifications..
2022
S.O. 5389(E) dt 18-11-2022 Corrigendum to S. O. 2164(E) dated 09.05.2022 based on the decision of the 103rd Authority meeting dated 10.11.2022.
S.O.-5389E-dt-18-11-2022-Corrigendum-to-S.-O.-2164E-dated-09.05.2022-based-on-the-decision-of-103rd-Authority-meeting-dated-10.11.2022.
S.O. 5388(E) dt 18-11-2022 NPPA has fixed retail prices of 40 formulations under DPCO 2013 based on the decision of the 103rd Authority meeting dated 10.11.2022.
S.O.-5388E-dt-18-11-2022-NPPA-has-fixed-retail-prices-of-40-formulations-under-DPCO-2013-based-on-the-decision-of-103rd-Authority-meeting-dated-10.11.2022.
S.O. 5249(E) dt 11-11-2022 – National List of Essential Medicines 2022 – EC Act 1955 (Drugs (Prices Control) Amendment Order, 2022.
S.O.-5249E-dt-11-11-2022-National-List-of-Essential-Medicines-2022-EC-Act-1955
O.M. dt 21-10-2022 Extension of the last date for filing statutory forms prescribed under DPCO, 2013
O.M.-dt-21-10-2022-Extension-of-last-date-for-filing-statutory-forms-prescribed-under-DPCO-2013
S.O. 4595(E) dt 29-09-2022 Extension Revised ceiling price of Dextrose Injection in 100ml pack having special features under Drugs (Prices Control) Order, 2013 based on the decision of 102nd Authority meeting dated 27.09.2022.
S.O.-4595E-dt-29-09-2022-Extension-Revised-ceiling-price-of-Dextrose-Injection-in-100ml-pack-having-special-features-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-102nd-Authority-meeting-dated-27.09.2022.
S.O. 4594(E) dt 29-09-2022 Extension Revised ceiling price of Mannitol Injection 20% in 100ml pack having special features under Drugs (Prices Control) Order, 2013 based on the decision of 102nd Authority meeting dated 27.09.2022.
S.O.-4594E-dt-29-09-2022-Extension-Revised-ceiling-price-of-Mannitol-Injection-20-in-100ml-pack-having-special-features-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-102nd-Authority-meeting-dated-27.09.2022.
S.O. 4593(E) dt 29-09-2022 Extension Revised ceiling price of Metronidazole Injection IP in 100ml pack having special features under Drugs (Prices Control) Order, 2013 based on the decision of 102nd Authority meeting dated 27.09.2022.
S.O.-4593E-dt-29-09-2022-Extension-Revised-ceiling-price-of-Metronidazole-Injection-IP-in-100ml-pack-having-special-features-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-102nd-Authority-meeting-dated-27.09.2022.
S.O. 4592(E) dt 29-09-2022 Extension of revised ceiling price of Ringer Lactate Injection having special features under Drugs (Prices Control) Order, 2013 based on the decision of 102nd Authority meeting dated 27.09.2022.
S.O.-4592E-dt-29-09-2022-Extension-of-revised-ceiling-price-of-Ringer-Lactate-Injection-having-special-features-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-102nd-Authority-meeting-dated-27.09.2022.
S.O. 4591(E) dt 29-09-2022 Extension of revised ceiling price of IV Fluid Injection having special features under Drugs (Prices Control) Order, 2013 based on the decision of 102nd Authority meeting dated 27.09.2022.
S.O.-4591E-dt-29-09-2022-Extension-of-revised-ceiling-price-of-IV-Fluid-Injection-having-special-features-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-102nd-Authority-meeting-dated-27.09.2022.
S.O. 4590(E) dt 29-09-2022 Extension of revised price of Liquid Medical Oxygen (LMO) and Oxygen Inhalation (Medicinal Gas) in cylinder under Drugs (Prices Control) Order, 2013 based on the decision of Authority meeting dated 27
S.O.-4590E-dt-29-09-2022-Extension-of-revised-price-of-Liquid-Medical-Oxygen-LMO-and-Oxygen-Inhalation-Medicinal-Gas-in-cylinder-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-Authority-meeting-dated-27
S.O. 4589(E) dt 29-09-2022 Extension of revised ceiling price of Heparin Injection under Drugs (Prices Control) Order, 2013 based on the decision of 102nd Authority meeting dated 27.09.2022.
S.O.-4589E-dt-29-09-2022-Extension-of-revised-ceiling-price-of-Heparin-Injection-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-102nd-Authority-meeting-dated-27.09.2022.
S.O. 4588(E) dt 29-09-2022 NPPA has fixed retail prices of 40 formulations under Drugs (Prices Control) Order, 2013 based on the decision of 102nd Authority meeting dated 27.09.2022
S.O.-4588E-dt-29-09-2022-NPPA-has-fixed-retail-prices-of-40-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-102nd-Authority-meeting-dated-27.09.2022.
S.O. 4343(E) dt 15-09-2022 Notification regarding extension of Knee implants under Drugs (Prices Control) Order, 2013.
S.O.-4343E-dt-15-09-2022-Notification-regarding-extension-of-Knee-implants-under-Drugs-Prices-Control-Order-2013.
S.O. 4342(E) dt 15-09-2022 NPPA has fixed retail prices of 1 formulation under Drugs (Prices Control) Order, 2013 (WPA) based on the decision of 101st Authority meeting dated 07.09.2022.
S.O.-4342E-dt-15-09-2022-NPPA-has-fixed-retail-prices-of-1-formulation-under-Drugs-Prices-Control-Order-2013-WPA-based-on-the-decision-of-101st-Authority-meeting-dated-07.09.2022.
S.O. 4341(E) dt 15-09-2022 NPPA has fixed retail prices of 36 formulations under the Drugs (Prices Control) Order, 2013 based on the decision of the 101st Authority meeting dated 07.09.2022.
S.O.-4341E-dt-15-09-2022-NPPA-has-fixed-retail-prices-of-36-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-101st-Authority-meeting-dated-07.09.2022.
OM dated 25.08.2022 relating to fixation of Ceiling Price of Sodium Chloride 0.45% Injection.
OM-dated-25.08.2022-relating-to-fixation-of-Ceiling-Price-of-Sodium-Chloride-0.45-Injection.
S.O. 4002(E) dt 24-08-2022 NPPA has fixed retail prices of 45 formulations under Drugs (Prices Control) Order, 2013 based on the decision of 100th Authority meeting dated 05.08.2022.
S.O.-4002E-dt-24-08-2022-NPPA-has-fixed-retail-prices-of-45-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-100th-Authority-meeting-dated-05.08.2022.
S.O. dt 29-07-2022 Notification regarding extension of capping of trade margin of 5 Medical Devices
S.O.-dt-29-07-2022-Notification-regarding-extension-of-capping-of-trade-margin-of-5-Medical-Devices
S.O. 2983(E) dt 30-06-2022 Notification regarding extension of price regulation on Oxygen Concentrator
S.O.-2983E-dt-30-06-2022-Notification-regarding-extension-of-price-regulation-on-Oxygen-Concentrator
S.O. 2982(E) dt 30-06-2022 Notification regarding extension of price regulation on LMO and Oxygen Inhalation
S.O.-2982E-dt-30-06-2022-Notification-regarding-extension-of-price-regulation-on-LMO-and-Oxygen-Inhalation
S.O. 2981(E) dt 30-06-2022 NPPA has fixed the retail prices of 84 new drugs based on the decision taken in 99th Authority meeting dated 28.06.2022
S.O.-2981E-dt-30-06-2022-NPPA-has-fixed-the-retail-prices-of-84-new-drugs-based-on-the-decision-taken-in-99th-Authority-meeting-dated-28.06.2022
S.O. 2465(E) dt 30-05-2022 Notification regarding extension of TMR notification on Oxygen Concentrators
S.O.-2465E-dt-30-05-2022-Notification-regarding-extension-of-TMR-notification-on-Oxygen-Concentrators
S.O. 2166 (E) DT 09-05-2022 NPPA has revised retail price of 1 formulation under Drugs (Prices Control) Order, 2013 based on review order.
S.O.-2166-E-DT-09-05-2022-NPPA-has-revised-retail-price-of-1-formulation-under-Drugs-Prices-Control-Order-2013-based-on-review-order.
S.O. 2165(E) Dt 09-05-2022 NPPA has fixed retail prices of 18 formulations under Drugs (Prices Control) Order, 2013 the price of which were applied earlier in the 96th Authority meeting dated 24.03.2022.
S.O.-2165E-Dt-09-05-2022-NPPA-has-fixed-retail-prices-of-18-formulations-under-Drugs-Prices-Control-Order-2013-the-price-of-which-were-applied-earlier-in-the-96th-Authority-meeting-dated-24.03.2022.
S.O. 2164(E) Dt 09-04-2022 NPPA has fixed retail prices of 66 formulations under Drugs (Prices Control) Order, 2013 based on the decision of 97th Authority meeting dated 06.05.2022.
S.O.-2164E-Dt-09-04-2022-NPPA-has-fixed-retail-prices-of-66-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-97th-Authority-meeting-dated-06.05.2022.
S.O. 1833(E) dt 18-04-2022 NPPA has fixed retail prices of 15 formulations under Drugs (Prices Control) Order, 2013 based on the decision of 96th Authority meeting dated 24.03.2022
S.O.-1833E-dt-18-04-2022-NPPA-has-fixed-retail-prices-of-15-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-96th-Authority-meeting-dated-24.03.2022
S.O. 1782(E) dt 12-04-2022 NPPA has fixed retail prices of 23 formulations under Drugs (Prices Control) Order, 2013 based on the decision of 96th Authority meeting dated 24.03.2022
S.O.-1782E-dt-12-04-2022-NPPA-has-fixed-retail-prices-of-23-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-96th-Authority-meeting-dated-24.03.2022
S.O. 1508(E) dt 30-03-2022 NPPA has fixed ceiling prices of Liquid Medical Oxygen, Medical Inhalation under Drugs (Prices Control) Order, 2013
S.O.-1508E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-Liquid-Medical-Oxygen-Medical-Inhalation-under-Drugs-Prices-Control-Order-2013
S.O. 1507(E) dt 30-03-2022 NPPA has fixed ceiling prices of Heparin Injection under Drugs (Prices Control) Order, 2013
S.O.-1507E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-Heparin-Injection-under-Drugs-Prices-Control-Order-2013
S.O. 1506(E) dt 30-03-2022 NPPA has fixed ceiling prices of Dextrose under Drugs (Prices Control) Order, 2013
S.O.-1506E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-Dextrose-under-Drugs-Prices-Control-Order-2013
S.O. 1505(E) dt 30-03-2022 NPPA has fixed ceiling prices of Mannitol under Drugs (Prices Control) Order, 2013
S.O.-1505E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-Mannitol-under-Drugs-Prices-Control-Order-2013
S.O. 1504(E) dt 30-03-2022 NPPA has fixed ceiling prices of Metronidazole under Drugs (Prices Control) Order, 2013
S.O.-1504E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-Metronidazole-under-Drugs-Prices-Control-Order-2013
S.O. 1503(E) dt 30-03-2022 NPPA has fixed ceiling prices of 9 formulations under Drugs (Prices Control) Order, 2013
S.O.-1503E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-9-formulations-under-Drugs-Prices-Control-Order-2013
S.O. 1502(E) dt 30-03-2022 NPPA has fixed ceiling prices of 2 Coronary stents under Drugs (Prices Control) Order, 2013
S.O.-1502E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-2-Coronary-stents-under-Drugs-Prices-Control-Order-2013
S.O. 1501(E) dt 30-03-2022 NPPA has fixed ceiling prices of 4 formulations under Drugs (Prices Control) Order, 2013
S.O.-1501E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-4-formulations-under-Drugs-Prices-Control-Order-2013
S.O. 1500(E) dt 30-03-2022 NPPA has fixed ceiling prices of 8 formulations under Drugs (Prices Control) Order, 2013
S.O.-1500E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-8-formulations-under-Drugs-Prices-Control-Order-2013
S.O. 1499(E) dt 30-03-2022 NPPA has fixed ceiling prices of 872 formulations under Drugs (Prices Control) Order, 2013
S.O.-1499E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-872-formulations-under-Drugs-Prices-Control-Order-2013
OM. dt 25-03-2022 Movement in Wholesale Price Index (WPI) for the preceding calendar year 2021
OM.-dt-25-03-2022-Movement-in-Wholesale-Price-Index-WPI-for-the-preceding-calendar-year-2021
S.O. 796(E) dt 18-02-2022 NPPA has fixed ceiling prices of 19 formulations under Drugs (Prices Control) Order, 2013
S.O.-796E-dt-18-02-2022-NPPA-has-fixed-ceiling-prices-of-19-formulations-under-Drugs-Prices-Control-Order-2013
S.O. 401(E) dt 31-01-2022 Extension of Trade Margin Rationalization on 5 Medical Devices, namely, Pulse Oximeter, Blood Pressure Monitoring Machine, Nebulizer, Digital Thermometer, and Glucometer
S.O.-401E-dt-31-01-2022-Extension-of-Trade-Margin-Rationalization-on-5-Medical-Devices-namely-Pulse-Oximeter-Blood-Pressure-Monitoring-Machine-Nebulizer-Digital-Thermometer-and-Glucometer
2021
S.O. 5428(E) dt 28-12-2021 Extension Revised ceiling price of Dextrose Injection in 100ml pack under Drugs (Prices Control) Order, 2013 based on the decision of 94th Authority meeting dated 23.12.2021.
S.O.-5428E-dt-28-12-2021-Extension-Revised-ceiling-price-of-Dextrose-Injection-in-100ml-pack-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-94th-Authority-meeting-dated-23.12.2021.
S.O. 5427(E) dt 28-12-2021 Extension Revised ceiling price of Mannitol Injection in 100ml pack under Drugs (Prices Control) Order, 2013 based on the decision of 94th Authority meeting dated 23.12.2021.
S.O.-5427E-dt-28-12-2021-Extension-Revised-ceiling-price-of-Mannitol-Injection-in-100ml-pack-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-94th-Authority-meeting-dated-23.12.2021.
S.O. 5426(E) dt 28-12-2021 Extension Revised ceiling price of Metronidazole Injection IP in 100ml pack under Drugs (Prices Control) Order, 2013 based on the decision of 94th Authority meeting dated 23.12.2021.
S.O.-5426E-dt-28-12-2021-Extension-Revised-ceiling-price-of-Metronidazole-Injection-IP-in-100ml-pack-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-94th-Authority-meeting-dated-23.12.2021.
S.O. 5425(E) dt 28-12-2021 NPPA has fixed ceiling prices of 2 formulations under Drugs (Prices Control) Order, 2013 based on the decision of 94th Authority meeting dated 23.12.2021.
S.O.-5425E-dt-28-12-2021-NPPA-has-fixed-ceiling-prices-of-2-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-94th-Authority-meeting-dated-23.12.2021.
S.O. 5424(E) dt 28-12-2021 Extension of price of Liquid Medical Oxygen (LMO) and Oxygen Inhalation (Medicinal Gas) in cylinder under Drugs (Prices Control) Order, 2013 based on the decision of 94th Authority meeting dated 23.12.2021.
S.O.-5424E-dt-28-12-2021-Extension-of-price-of-Liquid-Medical-Oxygen-LMO-and-Oxygen-Inhalation-Medicinal-Gas-in-cylinder-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-94th-Authority-meeting-dated-23.12.2021.
S.O. 5423(E) dt 28-12-2021 - NPPA has fixed retail prices of 28 formulations under Drugs (Prices Control) Order, 2013 based on the decision of 94th Authority meeting dated 23.12.2021.
S.O.-5423E-dt-28-12-2021-NPPA-has-fixed-retail-prices-of-28-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-94th-Authority-meeting-dated-23.12.2021.
S.O. 4885(E) dt 26-11-2021 NPPA has fixed ceiling prices of 2 formulations under Drugs (Prices Control) Order, 2013 based on the decision of 93rd Authority meeting dated 15.11.2021.
S.O.-4885E-dt-26-11-2021-NPPA-has-fixed-ceiling-prices-of-2-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-93rd-Authority-meeting-dated-15.11.2021.
S.O. 4884(E) dt 26-11-2021 NPPA has fixed retail prices of 47 formulations under Drugs (Prices Control) Order, 2013 based on the decision of 93rd Authority meeting dated 15.11.2021.
S.O.-4884E-dt-26-11-2021-NPPA-has-fixed-retail-prices-of-47-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-93rd-Authority-meeting-dated-15.11.2021.
OM dt 22-11-2021- on Paragraph 28 of DPCO, 2013 regarding refusal to sell drugs by manufacturers
OM-dt-22-11-2021-on-Paragraph-28-of-DPCO-2013-regarding-refusal-to-sell-drugs-by-manufacturers
S.O. 4241(E) dt 12-10-2021 - Addendum to S. O. 3934(E) dated 23.09.2021 - Methotrexate Topical Gel
S.O.-4241E-dt-12-10-2021-Addendum-to-S.-O.-3934E-dated-23.09.2021-Methotrexate-Topical-Gel
NPPA OM dt 30-09-2021 increase in GST rate - Medical Devices
NPPA-OM-dt-30-09-2021-increase-in-GST-rate-Medical-Devices
S.O. 3939(E) dt 23-09-2021 - Revised ceiling price of Dextrose Injection in 100ml pack under Drugs (Prices Control) Order, 2013 based on the decision of 92nd Authority meeting dated 08.09.2021.
S.O.-3939E-dt-23-09-2021-Revised-ceiling-price-of-Dextrose-Injection-in-100ml-pack-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-92nd-Authority-meeting-dated-08.09.2021.
S.O. 3938(E) dt 23-09-2021 - Revised ceiling price of Mannitol Injection 20% in 100ml pack under Drugs (Prices Control) Order, 2013 based on the decision of 92nd Authority meeting dated 08.09.2021.
S.O.-3938E-dt-23-09-2021-Revised-ceiling-price-of-Mannitol-Injection-20-in-100ml-pack-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-92nd-Authority-meeting-dated-08.09.2021.
S.O. 3937(E) dt 23-09-2021 - Revised ceiling price of Metronidazole Injection IP in 100ml pack under Drugs (Prices Control) Order, 2013 based on the decision of 92nd Authority meeting dated 08.09.2021.
S.O.-3937E-dt-23-09-2021-Revised-ceiling-price-of-Metronidazole-Injection-IP-in-100ml-pack-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-92nd-Authority-meeting-dated-08.09.2021.
Click for more articles on NPPA / DPCO
S.O. 3936(E) dt 23-09-2021 - Extension of price of Liquid Medical Oxygen (LMO) and Oxygen Inhalation (Medicinal Gas) in cylinder under Drugs (Prices Control) Order, 2013 based on the decision of 92nd Authority meeting dated 08.09.2021.
S.O.-3936E-dt-23-09-2021-Extension-of-price-of-Liquid-Medical-Oxygen-LMO-and-Oxygen-Inhalation-Medicinal-Gas-in-cylinder-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-92nd-Authority-meeting-dated-08.09.2021.
S.O. 3934(E) dt 23-09-2021 - NPPA has fixed retail prices of 23 formulations under Drugs (Prices Control) Order, 2013 based on the decision of 92nd Authority meeting dated 08.09.2021.
S.O.-3934E-dt-23-09-2021-NPPA-has-fixed-retail-prices-of-23-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-92nd-Authority-meeting-dated-08.09.2021.
S.O. (E) dt 23-09-2021 - Extension of revised ceiling price of Heparin Injection under Drugs (Prices Control) Order, 2013 based on the decision of 92nd Authority meeting dated 08.09.2021.
S.O.-E-dt-23-09-2021-Extension-of-revised-ceiling-price-of-Heparin-Injection-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-92nd-Authority-meeting-dated-08.09.2021.
S.O 3783(E) dt 15-09-2021 - NPPA has revised retail prices of 1 formulation under Drugs (Prices Control) Order, 2013 based on the decision of 91st Authority meeting dated 29.07.2021.
S.O-3783E-dt-15-09-2021-NPPA-has-revised-retail-prices-of-1-formulation-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-91st-Authority-meeting-dated-29.07.2021.
S.O. 3670(E) dt 10-09-2021 Regarding ceiling price fixation or revision of Orthopaedic Knee Implants for Knee Replacement System
S.O.-3670E-dt-10-09-2021-Regarding-ceiling-price-fixation-or-revision-of-Orthopaedic-Knee-Implants-for-Knee-Replacement-System
S.O. 3400(E) dt 19-08-2021 - NPPA has fixed retail prices of 19 formulations under Drugs (Prices Control) Order, 2013 based on the decision of 91st Authority meeting dated 29.07.2021
S.O.-3400E-dt-19-08-2021-NPPA-has-fixed-retail-prices-of-19-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-91st-Authority-meeting-dated-29.07.2021
S.O. 3249(E) dt 12-08-2021 - Amendment in paragraph 18 of DPCO, 2013
S.O.-3249E-dt-12-08-2021-Amendment-in-paragraph-18-of-DPCO-2013
S.O 3162(E) dt 06-08-2021 - NPPA has fixed retail prices of 6 formulations under Drugs (Prices Control) Order, 2013 based on the decision of 91st Authority meeting dated 29.07.2021
S.O-3162E-dt-06-08-2021-NPPA-has-fixed-retail-prices-of-6-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-91st-Authority-meeting-dated-29.07.2021
NPPA Office Memorandum 03-08-2021 - Submission of price related information for Knee Implants.
https://thehealthmaster.com/notifications/nppa-dpco-notifications/
Download the Latest notifications - NPPA / DPCO | Drugs Price Control Order, National Pharmaceuticals Pricing Authority
The Govt. of India issues notifications from time to time, which are published by the Department of Publication and are printed by the Government of India Printing Presses regularly.
We have provided some of the notifications relevant to the above-said topic, Click on the below links for more information:
2022
S.O.-5388E-dt-18-11-2022-NPPA-has-fixed-retail-prices-of-40-formulations-under-DPCO-2013-based-on-the-decision-of-103rd-Authority-meeting-dated-10.11.2022.
S.O.-5249E-dt-11-11-2022-National-List-of-Essential-Medicines-2022-EC-Act-1955 (Drugs (Prices Control) Amendment Order, 2022)
O.M.-dt-21-10-2022-Extension-of-last-date-for-filing-statutory-forms-prescribed-under-DPCO-2013
S.O.-4595E-dt-29-09-2022-Extension-Revised-ceiling-price-of-Dextrose-Injection-in-100ml-pack-having-special-features-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-102nd-Authority-meeting-dated-27.09.2022.
S.O.-4594E-dt-29-09-2022-Extension-Revised-ceiling-price-of-Mannitol-Injection-20-in-100ml-pack-having-special-features-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-102nd-Authority-meeting-dated-27.09.2022.
S.O.-4593E-dt-29-09-2022-Extension-Revised-ceiling-price-of-Metronidazole-Injection-IP-in-100ml-pack-having-special-features-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-102nd-Authority-meeting-dated-27.09.2022.
S.O.-4592E-dt-29-09-2022-Extension-of-revised-ceiling-price-of-Ringer-Lactate-Injection-having-special-features-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-102nd-Authority-meeting-dated-27.09.2022.
S.O.-4591E-dt-29-09-2022-Extension-of-revised-ceiling-price-of-IV-Fluid-Injection-having-special-features-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-102nd-Authority-meeting-dated-27.09.2022.
S.O.-4590E-dt-29-09-2022-Extension-of-revised-price-of-Liquid-Medical-Oxygen-LMO-and-Oxygen-Inhalation-Medicinal-Gas-in-cylinder-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-Authority-meeting-dated-27
S.O.-4589E-dt-29-09-2022-Extension-of-revised-ceiling-price-of-Heparin-Injection-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-102nd-Authority-meeting-dated-27.09.2022.
S.O.-4588E-dt-29-09-2022-NPPA-has-fixed-retail-prices-of-40-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-102nd-Authority-meeting-dated-27.09.2022.
S.O.-4343E-dt-15-09-2022-Notification-regarding-extension-of-Knee-implants-under-Drugs-Prices-Control-Order-2013.
S.O.-4342E-dt-15-09-2022-NPPA-has-fixed-retail-prices-of-1-formulation-under-Drugs-Prices-Control-Order-2013-WPA-based-on-the-decision-of-101st-Authority-meeting-dated-07.09.2022.
S.O.-4341E-dt-15-09-2022-NPPA-has-fixed-retail-prices-of-36-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-101st-Authority-meeting-dated-07.09.2022.
OM-dated-25.08.2022-relating-to-fixation-of-Ceiling-Price-of-Sodium-Chloride-0.45-Injection.
S.O.-4002E-dt-24-08-2022-NPPA-has-fixed-retail-prices-of-45-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-100th-Authority-meeting-dated-05.08.2022.
S.O.-dt-29-07-2022-Notification-regarding-extension-of-capping-of-trade-margin-of-5-Medical-Devices
S.O.-2983E-dt-30-06-2022-Notification-regarding-extension-of-price-regulation-on-Oxygen-Concentrator
S.O.-2982E-dt-30-06-2022-Notification-regarding-extension-of-price-regulation-on-LMO-and-Oxygen-Inhalation
S.O.-2981E-dt-30-06-2022-NPPA-has-fixed-the-retail-prices-of-84-new-drugs-based-on-the-decision-taken-in-99th-Authority-meeting-dated-28.06.2022
S.O.-2465E-dt-30-05-2022-Notification-regarding-extension-of-TMR-notification-on-Oxygen-Concentrators
S.O.-2166-E-DT-09-05-2022-NPPA-has-revised-retail-price-of-1-formulation-under-Drugs-Prices-Control-Order-2013-based-on-review-order.
S.O.-2165E-Dt-09-05-2022-NPPA-has-fixed-retail-prices-of-18-formulations-under-Drugs-Prices-Control-Order-2013-the-price-of-which-were-applied-earlier-in-the-96th-Authority-meeting-dated-24.03.2022.
S.O.-2164E-Dt-09-04-2022-NPPA-has-fixed-retail-prices-of-66-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-97th-Authority-meeting-dated-06.05.2022.
S.O.-1833E-dt-18-04-2022-NPPA-has-fixed-retail-prices-of-15-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-96th-Authority-meeting-dated-24.03.2022
S.O.-1782E-dt-12-04-2022-NPPA-has-fixed-retail-prices-of-23-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-96th-Authority-meeting-dated-24.03.2022
S.O.-1508E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-Liquid-Medical-Oxygen-Medical-Inhalation-under-Drugs-Prices-Control-Order-2013
S.O.-1507E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-Heparin-Injection-under-Drugs-Prices-Control-Order-2013
S.O.-1506E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-Dextrose-under-Drugs-Prices-Control-Order-2013
S.O.-1505E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-Mannitol-under-Drugs-Prices-Control-Order-2013
S.O.-1504E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-Metronidazole-under-Drugs-Prices-Control-Order-2013
S.O.-1503E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-9-formulations-under-Drugs-Prices-Control-Order-2013
S.O.-1502E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-2-Coronary-stents-under-Drugs-Prices-Control-Order-2013
S.O.-1501E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-4-formulations-under-Drugs-Prices-Control-Order-2013
S.O.-1500E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-8-formulations-under-Drugs-Prices-Control-Order-2013
S.O.-1499E-dt-30-03-2022-NPPA-has-fixed-ceiling-prices-of-872-formulations-under-Drugs-Prices-Control-Order-2013
OM.-dt-25-03-2022-Movement-in-Wholesale-Price-Index-WPI-for-the-preceding-calendar-year-2021
S.O.-796E-dt-18-02-2022-NPPA-has-fixed-ceiling-prices-of-19-formulations-under-Drugs-Prices-Control-Order-2013
2021
S.O.-401E-dt-31-01-2022-Extension-of-Trade-Margin-Rationalization-on-5-Medical-Devices-namely-Pulse-Oximeter-Blood-Pressure-Monitoring-Machine-Nebulizer-Digital-Thermometer-and-Glucometer
S.O.-5428E-dt-28-12-2021-Extension-Revised-ceiling-price-of-Dextrose-Injection-in-100ml-pack-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-94th-Authority-meeting-dated-23.12.2021.
S.O.-5427E-dt-28-12-2021-Extension-Revised-ceiling-price-of-Mannitol-Injection-in-100ml-pack-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-94th-Authority-meeting-dated-23.12.2021.
S.O.-5426E-dt-28-12-2021-Extension-Revised-ceiling-price-of-Metronidazole-Injection-IP-in-100ml-pack-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-94th-Authority-meeting-dated-23.12.2021.
S.O.-5425E-dt-28-12-2021-NPPA-has-fixed-ceiling-prices-of-2-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-94th-Authority-meeting-dated-23.12.2021.
S.O.-5424E-dt-28-12-2021-Extension-of-price-of-Liquid-Medical-Oxygen-LMO-and-Oxygen-Inhalation-Medicinal-Gas-in-cylinder-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-94th-Authority-meeting-dated-23.12.2021.
S.O.-5423E-dt-28-12-2021-NPPA-has-fixed-retail-prices-of-28-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-94th-Authority-meeting-dated-23.12.2021.
S.O.-4885E-dt-26-11-2021-NPPA-has-fixed-ceiling-prices-of-2-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-93rd-Authority-meeting-dated-15.11.2021.
S.O.-4884E-dt-26-11-2021-NPPA-has-fixed-retail-prices-of-47-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-93rd-Authority-meeting-dated-15.11.2021.
OM-dt-22-11-2021-on-Paragraph-28-of-DPCO-2013-regarding-refusal-to-sell-drugs-by-manufacturers
S.O.-4241E-dt-12-10-2021-Addendum-to-S.-O.-3934E-dated-23.09.2021-Methotrexate-Topical-Gel
NPPA-OM-dt-30-09-2021-increase-in-GST-rate-Medical-Devices
S.O.-3939E-dt-23-09-2021-Revised-ceiling-price-of-Dextrose-Injection-in-100ml-pack-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-92nd-Authority-meeting-dated-08.09.2021.
S.O.-3938E-dt-23-09-2021-Revised-ceiling-price-of-Mannitol-Injection-20-in-100ml-pack-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-92nd-Authority-meeting-dated-08.09.2021.
S.O.-3937E-dt-23-09-2021-Revised-ceiling-price-of-Metronidazole-Injection-IP-in-100ml-pack-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-92nd-Authority-meeting-dated-08.09.2021.
S.O.-3936E-dt-23-09-2021-Extension-of-price-of-Liquid-Medical-Oxygen-LMO-and-Oxygen-Inhalation-Medicinal-Gas-in-cylinder-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-92nd-Authority-meeting-dated-08.09.2021.
S.O.-3934E-dt-23-09-2021-NPPA-has-fixed-retail-prices-of-23-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-92nd-Authority-meeting-dated-08.09.2021.
S.O.-E-dt-23-09-2021-Extension-of-revised-ceiling-price-of-Heparin-Injection-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-92nd-Authority-meeting-dated-08.09.2021.
S.O-3783E-dt-15-09-2021-NPPA-has-revised-retail-prices-of-1-formulation-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-91st-Authority-meeting-dated-29.07.2021.
S.O.-3670E-dt-10-09-2021-Regarding-ceiling-price-fixation-or-revision-of-Orthopaedic-Knee-Implants-for-Knee-Replacement-System
S.O.-3400E-dt-19-08-2021-NPPA-has-fixed-retail-prices-of-19-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-91st-Authority-meeting-dated-29.07.2021
S.O.-3249E-dt-12-08-2021-Amendment-in-paragraph-18-of-DPCO-2013
S.O-3162E-dt-06-08-2021-NPPA-has-fixed-retail-prices-of-6-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-91st-Authority-meeting-dated-29.07.2021
NPPA-Office-Memorandum-03-08-2021-Submission-of-price-related-information-for-Knee-Implants
NPPA-Office-Memorandum-dt-23-07-2021-–-for-Revised-MRPs-in-pursuance-to-the-TMR-Notification-for-5-Medical-Devices
S.O.-2899E-dt-20-07-2021-Order-on-Amendment-in-the-Drugs-Prices-Control-Order-2013-for-inclusion-on-Form-VI
S.O.-2820E-dt-14-07-2021-NPPA-has-fixed-retail-prices-of-14-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-89th-Authority-meeting-dated-28.06.2021
NPPA-S.O.-2808-dt-13-07-2021-Trade-Margin-Rationalisation-TMR-of-5-Medical-Devices
S.O.-2742E-dt-08-07-2021-NPPA-has-fixed-retail-prices-of-11-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-89th-Authority-meeting-dated-28.06.2021
NPPA-Office-Memorandum-dt-05-07-2021-On-Ceiling-or-Retail-Price-for-Amphotericin-B-Emulsion-Injection-50mg.
S.O.-2654E-dt-01-07-2021-Revision-of-price-of-3-drugs-under-Para-19-of-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-89th-Authority-meeting-dated-28.06.2021.
S.O.-2653E-dt-01-07-2021-Exemption-to-Torrent-Pharmaceutical-for-Tapentadol-Nasal-Spray-under-Para-32-of-DPCO-2013-based-on-the-decision-of-89th-Authority-meeting-dated-28.06.2021
S.O-2334E-dt-15-06-2021-NPPA-has-fixed-retail-prices-of-3-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-87th-Authority-meeting-dated-25.05.2021.
NPPA-Dt-09-06-2021-Office-Memorandum-Revised-MRP-for-Oxygen-Concentrators
NPPA-Office-Memorandum-dt-04-06-2021-In-pursuance-to-the-Notification-dated-03.06.2021-for-Oxygen-Concentrators
NPPA-order-dt-03-06-2021-Price-Cap-for-Oxygen-Concentrator-through-Trade-Margin-Rationalisation-Approach
S.O-2119E-dt-01-06-2021-NPPA-has-fixed-retail-prices-of-12-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-87th-Authority-meeting-dated-27.05.2021.
NPPA-Office-Memorandum-dt-15-05-2021-for-call-of-MRP-Data-for-Pulse-Oximeter-Oxygen-Concentrator-2021
S.O.-1859-dt-14-05-2021-NPPA-has-fixed-retail-prices-of-2-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-86th-Authority-meeting-dated-28.04.2021
S.O.-1725-dt-30-04-2021-NPPA-has-fixed-ceiling-price-of-1-formulation-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-86th-Authority-meeting-dated-28.04.2021.
S.O.-1724-dt-30-04-2-21-NPPA-has-fixed-retail-prices-of-42-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-86th-Authority-meeting-dated-28.04.2021.
NPPA-Office-memorandum-dt-17-04-2021-List-of-Reduced-Prices-of-Remdesivir-of-7-companies
NPPA-12-04-2021-Remdesivir-Contact-Details-and-Helpline-Numbers-for-availability
S.O.-1335E-dt-25-03-2021-Prices-of-Liquid-Medical-Oxygen-and-Medicinal-gas-extended-upto-30-09-2021
S.O.-1334E-dt-25-03-2021-Revised-ceiling-prices-WPI-adjusted-for-two-2-Coronary-Stents.
S.O.-1333E-dt-25-03-2021-Revised-ceiling-prices-WPI-adjusted-of-4-pack-size-of-ringer-lactate-injection-with-packages-having-special-features.
S.O.-1332E-dt-25-03-2021-Revised-ceiling-prices-WPI-adjusted-of-8-IV-Fluids-with-packages-having-special-features.
S.O.-1331E-dt-25-03-2021-Revised-ceiling-price-WPI-adjusted-of-9-scheduled-formulations-of-Schedule-INLEM-2011-under-Drugs-Prices-Control-Order2013.
S.O.-1330E-dt-25-03-2021-Revised-ceiling-price-WPI-adjusted-of-866-scheduled-formulations-of-Schedule-I-under-Drugs-Prices-Control-Order-2013.
S.O.-1329E-dt-25-03-2021-NPPA-has-fixed-ceiling-price-of-1-formulation-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-84th-Authority-meeting-dated-10.03.2021.
S.O-1328E-dt-25-03-2021-NPPA-has-fixed-retail-prices-of-35-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-84th-Authority-meeting-dated-10.03.2021.
NPPA-Office-Memorandum-dt-18-03-2021-Movement-in-Wholesale-Price-Index-WPI-for-the-preceding-calendar-year-2020
S.O.-1238-dt-17-03-2021-Extension-of-S.O.-4539E-dated-18.12.2019-of-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-84th-Authority-meeting-dated-10.03.2021
S.O.-1237-dt-17-03-2021-Extension-of-S.O.-4538E-dated-18.12.2019-of-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-84th-Authority-meeting-dated-10.03.2021
S.O.-1236-dt-17-03-2021-Extension-of-revised-ceiling-price-of-Heparin-Injection-based-on-the-decision-of-84th-Authority-meeting-dated-10.03.2021
S.O.-1235-dt-17-03-2021-NPPA-has-fixed-retail-price-of-3-formulations-after-expiry-of-exemption-granted-under-para-32-of-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-84th-Authority-meeting-dated-10.03.2021
S.O.-1208-dt-15-03-2021-NPPA-has-fixed-retail-prices-of-41-formulations-under-Drugs-Prices-Control-Order-2013-based-on-the-decision-of-84th-Authority-meeting-dated-10.03.2021
NPPA-dt-12-03-2021-Monitoring-of-MRPs-for-Medical-Devices-dated-16.02.2021-with-Annexures
NPPA-dt-18-02-2021-Display-of-draft-version-of-proposed-price-calculation-sheet-for-24-proposed-retail-price-based-on-June-2020-Data-under-Para-4-of-DPCO-2013
NPPA-Office-Memorandum-dt-16-02-2021-on-Monitoring-of-MRPs-for-Medical-Devices-with-Annexures
S.-O.-575-E-dt-09-02-2021-NPPA-has-fixed-the-ceiling-prices-of-13-formulations-under-Drugs-Prices-Control-Order-2013
S.-O.-523-E-dt-04-02-2021-NPPA-has-fixed-the-ceiling-prices-of-8-formulations-under-Drugs-Prices-Control-Order-2013-relating-to-83rd-Authority-meeting-dated-27-01-2021
S.O.-508E-dt-01-02-2021-Amendment-in-Schedule-I-of-the-DPCO-2013
NPPA-Memorandum-dt-11-01-2021-Provisional-List-of-324-Over-Charging-cases-under-litigation
S.-O.-95-E-dt-08-01-2021-NPPA-has-fixed-the-ceiling-prices-of-12-formulations-under-Drugs-Prices-Control-Order-2013-relating-to-82nd-Authority-meeting-dated-23-12-2020
2020
S.-O.-4774-E-dt-31-12-2020-Price-exemption-of-FDC-of-Sun-Pharma-under-para-321-of-DPCO-2013-relating-to-82nd-Authority-meeting-dated-23-12-2020
S.-O.-4773-E-dt-31-12-2020-NPPA-has-fixed-the-ceiling-prices-of-7-formulations-under-Drugs-Prices-Control-Order-2013-relating-to-82nd-Authority-meeting-dated-23-12-2020
S. O. 4498(E) dt 11-12-2020 – NPPA has fixed the ceiling prices of 3 formulations under Drugs (Prices Control) Order, 2013 relating to 81th Authority meeting dated 24.11.2020
S.O-4333E-dt-03-12-2020-Extension-of-revised-price-of-Heparin-Injection-based-on-the-decision-of-81st-Authority-meeting-dated-24.11.2020
SO-3977-E-dt-03-11-2020-NPPA-has-fixed-the-ceiling-prices-of-2-formulations-under-Drugs-Prices-Control-Order-2013-relating-to-80th-Authority-meeting-dated-26.10.2020PDF-icon
SO-3976-E-dt-03-11-2020-NPPA-has-fixed-the-ceiling-prices-of-6-formulations-under-Drugs-Prices-Control-Order-2013-relating-to-80th-Authority-meeting-dated-26.10.2020
SO-3975-E-dt-03-11-2020-Addendum-to-SO.-1216-E-dated-25.03.2020-relating-to-80th-Authority-meeting-dated-26.10.2020
SO-3974-E-dt-03-11-2020-Addendum-to-SO.-1215-E-dated-25.03.2020-relating-to-80th-Authority-meeting-dated-26.10.2020
S.O.-3973E-dt.-03-11-2020-NPPA-has-fixed-retail-prices-of-29-formulations-under-Drugs-Prices-Control-Order-2013-relating-to-80th-Authority-meeting-dated-26-10-2020
S.O.-3322-E-dt-25-09-2020-Price-Cap-for-Medical-Liquid-Oxygen-and-Oxygen-Inhalation-Medicinal-gas-in-Cylinder
S.O.-3319-E-dt-25-09-2020-NPPA-has-fixed-retail-prices-of-26-formulations-under-Drugs-Prices-Control-Order-2013-relating-to-78th-Authority-meeting-dated-14.09.2020
Office-memorandum-dt-25-09-2020-–-Clarification-regarding-revision-of-Ceiling-Prices-of-Orthopaedic-Knee-Implants-for-the-year-2020
NPPA-order-dt-24-09-2020-for-submission-of-data-by-manufacturers-and-re-fillers-of-medical-oxygen
S.O.-3147E-15-09-2020-Notification-regarding-ceiling-price-fixation-revision-of-orthopedic-Knee-Implants-for-Knee-Replacement-System
S.O.-No.-2896-dt-27-08-2020-NPPA-has-fixed-retail-prices-of-1-formulation-under-Drugs-Prices-Control-Order-2013-relating-to-77th-Authority-meeting-dated-06.08.2020
S.O.-2822E-dt-20-08-2020-NPPA-has-fixed-retail-prices-of-29-formulations-under-Drugs-Prices-Control-Order-2013-relating-to-77th-Authority-meeting-dated-06.08.2020
NPPA-Office-memorandum-dt.-14-08-2020-Guidelines-for-Discontinuation-of-Scheduled-Formulation
S.O.-No.-2768-E-dated-14-08-2020-regarding-prices-of-Knee-implants-extended-upto-15-09-2020
S.O.-2293E-dt.-10-07-2020-NPPA-HAS-FIXED-RETAIL-PRICES-OF-7-FORMULATIONS-UNDER-DRUGS-PRICES-CONTROL-ORDER-2013-RELATING-TO-76TH-AUTHORITY-MEETING-DATED-22.06.2020
S.O.-2292E-dt.-10-07-2020-REVISION-OF-CEILING-PRICE-OF-1-FORMULATION-BASED-ON-REVIEW-ORDER-RELATING-TO-76TH-AUTHORITY-MEETING-DATED-22.06.2020
SO-2151E-dt-30-06-2020-Revised-ceiling-price-of-Heparin
S.O. 2150 dt. 30-06-2020 – NPPA has fixed retail prices of 14 formulations under Drugs (Prices Control) Order, 2013
NPPA-Office-Memorandum-dt-03-06-2020-regarding-revised-MRPs-of-N-95-masks
NPPA-dt-01-06-2020-Draft-guidelines-for-dealing-cases-of-discontinuation-of-scheduled-formulations-under-Para-21-2-of-DPCO 2013.
S.O.-1674 (E) 28-05-2020 NPPA has fixed revised retail prices of 40 formulation under Drugs (Prices Control) Order, 2013
NPPA-OM-Dt-14-08-2020-Guidelines-for-Discontinuation-of-Scheduled-Formulation
S.O-No.-1232-E-dt-31-03-2020-All-Medical-devices-under-DPCO
NPPA-Order-dated-25.03.2020-to-maintain-stock-of-Lopinavir-Ritonavir-Tablets
S.O.-1217-dt-25-03-2020-NPPA-has-fixed-revised-retail-prices-of-2-items-Stents-under-Drugs-Prices-Control-Order-2013
S.O.-1216-dt-25-03-2020-16-items-Ringer-Lactate-Price-revision-as-per-annual-wholesale-price-Index-WPI-@-1.88468-increase
S.O.-1215-dt-25-03-2020-8-items-Glucose-Sod-Chloride-etc.-Price-revision-as-per-annual-wholesale-price-Index-WPI-@-1.88468-increase
S.O.-1214-dt-25-03-2020-13-items-Salicylic-acid-Cal-carbonate-Condom-etc.-Price-revision-as-per-annual-wholesale-price-Index-WPI-@-1.88468-increase
S.O.-1213-dt-25-03-2020-856-items-Price-revision-as-per-annual-wholesale-price-Index-WPI-@-1.88468-increase
S.O.-07-02-2020-NPPA-has-fixed-retail-prices-of-21-formulations-under-Drugs-Prices-Control-Order-2013
S.O.
https://thehealthmaster.com/2021/02/14/latest-notifications-nppa-dpco/
Subscribe to:
Posts (Atom)